Altered glutamine metabolism and therapeutic opportunities for lung cancer

Clinical Lung Cancer

Volumn 15, Issue 1, 2014, Pages 7-15

  Mohamed, Amr ^a   Deng, Xingming ^a   Khuri, Fadlo R ^a   Owonikoko, Taofeek K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer metabolism; Glutaminase; Glutamine; Imaging; Lung cancer

Indexed keywords

GLUTAMINE;

CANCER CELL; CANCER THERAPY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DRUG TARGETING; HUMAN; IMAGING; LUNG CANCER; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

CANCER METABOLISM; GLUTAMINASE; GLUTAMINE; IMAGING; LUNG CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; ENERGY METABOLISM; GLUTAMINE; GLYCOLYSIS; HUMANS; NEOPLASMS;

EID: 84891774010     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.09.001     Document Type: Review

References (106)

1. S.S. Ramalingam, T.K. Owonikoko, and F.R. Khuri Lung cancer: new biological insights and recent therapeutic advances CA Cancer J Clin 61 2011 91 112
2. J.F. Vansteenkiste, and S.S. Stroobants PET scan in lung cancer: current recommendations and innovation J Thorac Oncol 1 2006 71 73
3. B.A. Teicher, W.M. Linehan, and L.J. Helman Targeting cancer metabolism Clin Cancer Res 18 2012 5537 5545
4. M.G. Vander Heiden, J.W. Locasale, and K.D. Swanson et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells Science 329 2010 1492 1499
5. T. Hitosugi, L. Zhou, and S. Elf et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth Cancer Cell 22 2012 585 600
6. C.V. Dang Rethinking the Warburg effect with Myc micromanaging glutamine metabolism Cancer Res 70 2010 859 862
7. K. Shukla, D.V. Ferraris, and A.G. Thomas et al. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES) analogs as glutaminase inhibitors J Med Chem 55 2012 10551 10563
8. J. Bergstrom, P. Furst, and L.O. Noree et al. Intracellular free amino acid concentration in human muscle tissue J Appl Physiol 36 1974 693 697
9. T.R. Austgen, R. Chakrabarti, and M.K. Chen et al. Adaptive regulation in skeletal muscle glutamine metabolism in endotoxin-treated rats J Trauma 32 1992 600 606 discussion 606-7
10. M.A. Medina, F. Sanchez-Jimenez, and J. Marquez et al. Relevance of glutamine metabolism to tumor cell growth Mol Cell Biochem 113 1992 1 15
11. W.W. Souba Interorgan ammonia metabolism in health and disease: a surgeon's view JPEN J Parenter Enteral Nutr 11 1987 569 579
12. P. Newsholme, M.M. Lima, and J. Procopio et al. Glutamine and glutamate as vital metabolites Braz J Med Biol Res 36 2003 153 163
13. J.T. Brosnan Interorgan amino acid transport and its regulation J Nutr 133 2003 2068S 2072S
14. M. Yuneva, N. Zamboni, and P. Oefner et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells J Cell Biol 178 2007 93 105
15. A.G. Craan, G. Lemieux, and P. Vinay et al. The kidney of chicken adapts to chronic metabolic acidosis: in vivo and in vitro studies Kidney Int 22 1982 103 111
16. H.K. Berman, R.M. O'Doherty, and P. Anderson et al. Overexpression of protein targeting to glycogen (PTG) in rat hepatocytes causes profound activation of glycogen synthesis independent of normal hormone- and substrate-mediated regulatory mechanisms J Biol Chem 273 1998 26421 26425
17. M.J. Hubbard, and P. Cohen On target with a new mechanism for the regulation of protein phosphorylation Trends Biochem Sci 18 1993 172 177
18. A. Meister, and M.E. Anderson Glutathione Annu Rev Biochem 52 1983 711 760
19. A. Meister Glutathione, ascorbate, and cellular protection Cancer Res 54 1994 1969s 1975s
20. W.W. Souba Glutamine and cancer Ann Surg 218 1993 715 728
21. H. Eagle Nutrition needs of mammalian cells in tissue culture Science 122 1955 501 514
22. L.J. Reitzer, B.M. Wice, and D. Kennell Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells J Biol Chem 254 1979 2669 2676
23. Z. Kovacevic, and H.P. Morris The role of glutamine in the oxidative metabolism of malignant cells Cancer Res 32 1972 326 333
24. J.E. Fischer, and W.T. Chance Total parenteral nutrition, glutamine, and tumor growth JPEN J Parenter Enteral Nutr 14 1990 86S 89S
25. B.P. Bode, B.C. Fuchs, and B.P. Hurley et al. Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells Am J Physiol Gastrointest Liver Physiol 283 2002 G1062 G1073
26. B.P. Bode, D.L. Kaminski, and W.W. Souba et al. Glutamine transport in isolated human hepatocytes and transformed liver cells Hepatology 21 1995 511 520
27. B. Drogat, M. Bouchecareilh, and S. North et al. Acute L-glutamine deprivation compromises VEGF-a upregulation in A549/8 human carcinoma cells J Cell Physiol 212 2007 463 472
28. K.R. Huber, E.P. Mayer, and D.F. Mitchell et al. Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines Br J Cancer 55 1987 653 656
29. M. Brower, D.N. Carney, and H.K. Oie et al. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium Cancer Res 46 1986 798 806
30. H.N. Christensen Role of amino acid transport and countertransport in nutrition and metabolism Physiol Rev 70 1990 43 77
31. W.W. Souba, and A.J. Pacitti How amino acids get into cells: mechanisms, models, menus, and mediators JPEN J Parenter Enteral Nutr 16 1992 569 578
32. P. Boerner, and M.H. Saier Jr. Adaptive regulatory control of System A transport activity in a kidney epithelial cell line (MDCK) and in a transformed variant (MDCK-T1) J Cell Physiol 122 1985 308 315
33. S. Sastrasinh, and M. Sastrasinh Glutamine transport in submitochondrial particles Am J Physiol 257 1989 F1050 F1058
34. S. Rivera, J. Azcon-Bieto, and F.J. Lopez-Soriano et al. Amino acid metabolism in tumour-bearing mice Biochem J 249 1988 443 449
35. W.W. Souba, F.R. Strebel, and J.M. Bull et al. Interorgan glutamine metabolism in the tumor-bearing rat J Surg Res 44 1988 720 726
36. A.J. Pacitti, M.K. Chen, and K.I. Bland et al. Mechanisms of accelerated hepatic glutamine efflux in the tumour-bearing rat Surg Oncol 1 1992 173 182
37. W.E. Knox, M.L. Horowitz, and G.H. Friedell The proportionality of glutaminase content to growth rate and morphology of rat neoplasms Cancer Res 29 1969 669 680
38. M.K. Chen, R.M. Salloum, and T.R. Austgen et al. Tumor regulation of hepatic glutamine metabolism JPEN J Parenter Enteral Nutr 15 1991 159 164
39. M.J. Rennie, P.A. MacLennan, and H.S. Hundal et al. Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover Metabolism 38 1989 47 51
40. R.M. Salloum, E.M. Copeland 3rd, and K.I. Bland et al. Selective stimulation of brush border glutamine transport in the tumor-bearing rat J Surg Res 50 1991 391 397
41. A.J. Pacitti, Y. Inoue, and W.W. Souba Characterization of Na(+)-independent glutamine transport in rat liver Am J Physiol 265 1993 G90 G98
42. A.J. Pacitti, Y. Inoue, and W.W. Souba Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver J Clin Invest 91 1993 474 483
43. H.N. Langstein, and J.A. Norton Mechanisms of cancer cachexia Hematol Oncol Clin North Am 5 1991 103 123
44. A.P. van den Heuvel, J. Jing, and R.F. Wooster et al. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth Cancer Biol Ther 13 2012 1185 1194
45. S. Hori, S. Nishiumi, and K. Kobayashi et al. A metabolomic approach to lung cancer Lung Cancer 74 2011 284 292
46. J. Long, H. Wang, and Z. Lang et al. Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B Hepatol Int 5 2011 698 706
47. N.P. Curthoys, and M. Watford Regulation of glutaminase activity and glutamine metabolism Annu Rev Nutr 15 1995 133 159
48. J.M. Carrascosa, P. Martinez, and I. Nunez de Castro Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells Cancer Res 44 1984 3831 3835
49. P. Nicklin, P. Bergman, and B. Zhang et al. Bidirectional transport of amino acids regulates mTOR and autophagy Cell 136 2009 521 534
50. K. Kaira, N. Oriuchi, and H. Imai et al. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung Pathol Res Pract 204 2008 553 561
51. K. Kaira, T. Takahashi, and H. Murakami et al. Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence Anticancer Res 31 2011 3775 3782
52. H. Imai, K. Kaira, and N. Oriuchi et al. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer Anticancer Res 30 2010 4819 4828
53. K. Kaira, N. Oriuchi, and T. Takahashi et al. LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer Am J Transl Res 3 2011 468 478
54. M. Hassanein, M.D. Hoeksema, and M. Shiota et al. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival Clin Cancer Res 19 2013 560 570
55. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu Rev Pharmacol Toxicol 37 1997 205 237
56. Y.E. Marin, J. Namkoong, and K. Cohen-Solal et al. Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon Cell Signal 18 2006 1279 1286
57. S.S. Shin, B.A. Wall, and J.S. Goydos et al. AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1) Pigment Cell Melanoma Res 23 2010 103 111
58. J. Namkoong, S.S. Shin, and H.J. Lee et al. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma Cancer Res 67 2007 2298 2305
59. W. Rzeski, L. Turski, and C. Ikonomidou Glutamate antagonists limit tumor growth Proc Natl Acad Sci U S A 98 2001 6372 6377
60. D.R. Wise, R.J. DeBerardinis, and A. Mancuso et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc Natl Acad Sci U S A 105 2008 18782 18787
61. M. Volm, P. Drings, and W. Wodrich et al. Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases Clin Exp Metastasis 11 1993 325 329
62. A.J. Levine, and A.M. Puzio-Kuter The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes Science 330 2010 1340 1344
63. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
64. F. Weinberg, R. Hamanaka, and W.W. Wheaton et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity Proc Natl Acad Sci U S A 107 2010 8788 8793
65. Z. Weaver, S. Difilippantonio, and J. Carretero et al. Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response Cancer Res 72 2012 5921 5933
66. B.R. Balsara, J. Pei, and Y. Mitsuuchi et al. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions Carcinogenesis 25 2004 2053 2059
67. J. Huang, and B.D. Manning The TSC1-TSC2 complex: a molecular switchboard controlling cell growth Biochem J 412 2008 179 190
68. K. Hara, K. Yonezawa, and Q.P. Weng et al. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism J Biol Chem 273 1998 14484 14494
69. A. Baskerville, P. Hambleton, and J.E. Benbough Pathological features of glutaminase toxicity Br J Exp Pathol 61 1980 132 138
70. J.M. Mehnert, N. Semlani, and Y. Wen et al. A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma J Clin Oncol 30 2012 TPS3112
71. J.M. Mehnert, J.H. Lee, and J. Shirk et al. A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in metastatic melanoma J Clin Oncol 28 2012 TPS309
72. D. Yip, M.N. Le, and J.L. Chan et al. A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma Clin Cancer Res 15 2009 3896 3902
73. C. Unger, C. Mueller, and M.P. Bausch et al. A phase I schedule optimization study of pegylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-l- norleucine (DON) in patients (pts) with advanced solid tumors J Clin Oncol 29 2011 3049
74. C. Mueller, S. Al-Batran, and E. Jaeger et al. A phase I trial of PEGylated glutaminase (PEG-PGA) in combination with 6-diazo-5-oxo-L-norleucine (DON) in advanced, refractory, solid tumors J Clin Oncol 25 2007 14040
75. C. Mueller, S. Al-Batran, and E. Jaeger et al. A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors J Clin Oncol 26 2008 2533
76. R. Harzmann, N. Esser, and R. Loewe et al. Glutaminase (PEG-PGA) increases antitumoral efficacy of cytotoxic agents J Clin Oncol 22 2004 3183
77. M. Nakatsugawa, Y. Hirohashi, and T. Torigoe et al. Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4 Cancer Sci 100 2009 1485 1493
78. M. Nakatsugawa, K. Horie, and T. Yoshikawa et al. Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin Int J Oncol 39 2011 1041 1049
79. B.S. Kramer, R. Birch, and A. Greco et al. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial Cancer Treat Rep 70 1986 1031 1032
80. P. Bonomi, D. Finkelstein, and A. Chang Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study Am J Clin Oncol 17 1994 215 217
81. F.M. Iwamoto, T.N. Kreisl, and L. Kim et al. Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas Cancer 116 2010 1776 1782
82. W.P. Katt, S. Ramachandran, and J.W. Erickson et al. Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation Mol Cancer Ther 11 2012 1269 1278
83. B.P. Lieberman, K. Ploessl, and L. Wang et al. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine J Nucl Med 52 2011 1947 1955
84. W. Qu, S. Oya, and B.P. Lieberman et al. Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors J Nucl Med 53 2012 98 105
85. G.S. Ahluwalia, J.L. Grem, and Z. Hao et al. Metabolism and action of amino acid analog anti-cancer agents Pharmacol Ther 46 1990 243 271
86. H. Suwa, G. Ohshio, and T. Imamura et al. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas Br J Cancer 77 1998 147 152
87. J.P. Mira, V. Benard, and J. Groffen et al. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway Proc Natl Acad Sci U S A 97 2000 185 189
88. J.B. Wang, J.W. Erickson, and R. Fuji et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation Cancer Cell 18 2010 207 219
89. J.W. Erickson, and R.A. Cerione Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 1 2010 734 740
90. K. Gaurav, R.K. Goel, and M. Shukla et al. Glutamine: a novel approach to chemotherapy-induced toxicity Indian J Med Paediatr Oncol 33 2012 13 20
91. D.L. Kisner, R. Catane, and F.M. Muggia The rediscovery of DON (6-diazo-5-oxo-L-norleucine) Recent Results Cancer Res 74 1980 258 263
92. G. Weber, and N. Prajda Targeted and non-targeted actions of anti-cancer drugs Adv Enzyme Regul 34 1994 71 89
93. L.M. Shelton, L.C. Huysentruyt, and T.N. Seyfried Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model Int J Cancer 127 2010 2478 2485
94. A.A. Ovejera, D.P. Houchens, and R. Catane et al. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6- diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice Cancer Res 39 1979 3220 3224
95. K.E. Nichols, S.R. Chitneni, and J.O. Moore et al. Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin Blood 74 1989 1728 1737
96. J.A. Maroun, A.L. Fields, and J.L. Pater et al. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study Cancer Treat Rep 68 1984 1121 1123
97. P.H. Patel, R.S. Chaganti, and R.J. Motzer Targeted therapy for metastatic renal cell carcinoma Br J Cancer 94 2006 614 619
98. M.J. Seltzer, B.D. Bennett, and A.D. Joshi et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1 Cancer Res 70 2010 8981 8987
99. E. Topkan, M.N. Yavuz, and C. Onal et al. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters Lung Cancer 63 2009 393 399
100. E. Topkan, C. Parlak, and S. Topuk et al. Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer BMC Cancer 12 2012 502
101. K.N. Rajagopalan, and R.J. DeBerardinis Role of glutamine in cancer: therapeutic and imaging implications J Nucl Med 52 2011 1005 1008
102. S.S. Gambhir Molecualr imaging of cancer: from molecules to humans. Introduction J Nucl Med 49 suppl 2 2008 1S 4S
103. D. Daye, and K.E. Wellen Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis Semin Cell Dev Biol 23 2012 362 369
104. W. Qu, Z. Zha, and K. Ploessl et al. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors J Am Chem Soc 133 2011 1122 1133
105. K. Ploessl, L. Wang, and B.P. Lieberman et al. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents J Clin Nucl Med 53 2012 1616 1624
106. R.J. DeBerardinis, A. Mancuso, and E. Daikhin et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proc Natl Acad Sci U S A 104 2007 19345 19350